Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
166.6 USD | +0.28% | -1.19% | +7.48% |
Jun. 13 | AbbVie inks immune disorder drug licensing deal with China's FutureGen | RE |
Jun. 13 | AbbVie, FutureGen in License Pact for Inflammatory Bowel Disease Drug | DJ |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- ABBV Stock
- Revisions AbbVie Inc.